University of Arkansas for Medical Sciences (UAMS) researchers have received a $11.4 million grant to study the side effects of cancer therapies.
The grant, provided by the Centers for Biomedical Research Excellence (COBRE), will run for years. Marjan Boerma, Ph.D., the director for the Center of Studies of Host Reponse to Cancer Therapy as well as the director for the Division of Radiation Health, will led the research.
As part of the research, the group will look at how and why side effects are caused by therapies. In addition, they will work to develop prevention strategies for the side effects.
“We are grateful for the renewed funding from COBRE at a higher level than even five years ago,” UAMS College of Pharmacy Dean Cindy Stowe, Pharm.D, said in a statement. “The center still is one of the very few research centers studying the side effects of cancer therapies like chemo and radiation and looking for ways to minimize or eliminate those side effects. This grant is confirmation to us that NIH also sees the value in the work being done by the center.”